Key messages

  • A medical or nurse practitioner involved in a methadone or buprenorphine program must inform the department if a patient is terminated from a program.
  • There are several reasons for terminating a patient’s pharmacotherapy.
  • If an incarcerated patient is on a pharmacotherapy program and is released from prison, this must be notified in addition to the regular notification.

Approved medical practitioners or nurse practitioners need to notify the department if a patient’s participation in a methadone or buprenorphine program is terminated.

Reasons for a patient’s termination include:

  • transfer to another practitioner
  • hospitalisation
  • imprisonment
  • ceased to dose methadone or buprenorphine
  • requested to leave by doctor
  • did not start a program
  • discharged from hospital
  • released from prison
  • completed the program
  • deceased.

The notification of termination of a methadone or buprenorphine program is a requirement under the Drugs, Poisons and Controlled Substances Act 1981.

If an incarcerated patient is on a pharmacotherapy program and is released from prison, this must be notified in addition to the regular notification.

Contact details